摘要
目的:泛素参与细胞增殖和分化,本研究的目的是在兔PCO模型中通过腺病毒表达载体在预防中检测6位(K6W)的赖氨酸与色氨酸突变的显性负泛素(Ub)的后囊膜不透明(PCO)的潜力。 方法:用QBI-HEK 293A细胞产生具有绿色荧光蛋白(RAd-K6W-Ub / GFP)和RAd-GFP病毒(对照)的重组显性阴性K6W-Ub腺病毒(RAd-K6W-Ub) 接受镜片晶状体乳化术的新西兰兔子给予了术中前房内注射的病毒。运用裂隙灯生物显微镜拍摄的前段摄影图像通过后囊膜混浊人工软件(POCOman)进行PCO分级分析。用非接触眼压计(NCT)检测眼内压(IOP)。通过蛋白质印迹法检测α-平滑肌肌动蛋白(α-SMA)的表达。通过划痕愈合试验评估培养的兔子晶状体上皮细胞(LEC)中的细胞迁移能力。 结果:注射48小时后,镜片上皮中GFP和Ub的表达明显上调。 注射RAd-K6W-Ub的眼睛与对照组相比显示PCO程度明显降低。同时,RAd-K6W-Ub病毒剂量较高的组观察到较高的眼压和角膜水肿。与对照组相比,RAD-K6W-Ub眼中α-SMA的表达下调。细胞迁移被RAd-K6W-Ub抑制。 结论:适当剂量的RAD-K6W-Ub可以抑制兔子LECs的增殖和PCO的形成。 然而,较高剂量的Rad-K6W-Ub病毒载体对周围组织造成毒性作用,如角膜水肿和高IOP。
关键词: 后囊膜不透明(PCO),K6W-泛素,泛素 - 蛋白酶体途径(UPP),晶状体上皮细胞(LEC),腺病毒载体
Current Molecular Medicine
Title:Expression of Dominant Negative K6W-Ubiquitin in the Lens Epithelium via an Adenoviral Vector Delays Posterior Capsule Opacification in a Rabbit Model
Volume: 17 Issue: 2
关键词: 后囊膜不透明(PCO),K6W-泛素,泛素 - 蛋白酶体途径(UPP),晶状体上皮细胞(LEC),腺病毒载体
摘要: Purpose: Ubiquitin is involved in cell proliferation and differentiation, and the objective of this study is to investigate the potential of dominant negative Ubiquitin (Ub) with a lysine to tryptophan mutation at the 6 position (K6W) through an adenoviral expression vector in the prevention of posterior capsule opacification (PCO) in a rabbit PCO model.
Methods: Recombinant dominant negative K6W-Ub adenovirus (RAd-K6W-Ub) with green fluorescent protein (RAd-K6W-Ub/GFP) and RAd-GFP viruses (control) were generated with QBI-HEK 293A cells. New Zealand rabbits receiving lens phacoemulsification were given an intraoperative anterior chamber injection of the viruses. The images of anterior segment photography taken by a slit lamp biomicroscopy were analyzed by posterior capsule opacification manual software (POCOman) for PCO grading. The intraocular pressure (IOP) was detected with a non-contact tonometer (NCT). The expression of α-smooth muscle actin (α-SMA) was assessed by Western blotting. Cell migration ability in cultured rabbit’s lens epithelial cells (LECs) was evaluated by scratch healing assay. Results: The expression of GFP and Ub in the lens epithelium was markedly upregulated after 48 hours vector injection. Eyes injected with RAd-K6W-Ub showed a significantly lower PCO degree compared with controls. Meanwhile, higher IOP and corneal edema was observed in groups with a higher RAd-K6W-Ub virus dosage. The expression of α-SMA was down-regulated in the RAd-K6W-Ub eyes as compared to controls at the 15th day after injection. Cell migration was inhibited by RAd-K6W-Ub infection. Conclusions: RAd-K6W-Ub at an appropriate dosage could inhibit the proliferation of LECs and the formation of PCO in rabbit models. However, a higher dosage of Rad- K6W-Ub viral vector caused toxic effects to the surrounding tissues, such as corneal edema and high IOP.Export Options
About this article
Cite this article as:
Expression of Dominant Negative K6W-Ubiquitin in the Lens Epithelium via an Adenoviral Vector Delays Posterior Capsule Opacification in a Rabbit Model, Current Molecular Medicine 2017; 17 (2) . https://dx.doi.org/10.2174/1566524017666170331163751
DOI https://dx.doi.org/10.2174/1566524017666170331163751 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Vaccines and Delivery Strategies for Adult Immunization
Current Immunology Reviews (Discontinued) Heterocycles in the Treatment of Neglected Tropical Diseases
Current Medicinal Chemistry Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center
Reviews on Recent Clinical Trials Hydroxychloroquine Sulfate (Plaquenil): A Possible Candidate for Pandemic SARS-CoV-2 or (COVID-19) ?
Coronaviruses Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping
Current Molecular Pharmacology Phytochemical and Analytical Evaluation of Kachnal (Bauhinia racemosa Lam.) Bark
Current Traditional Medicine The Protein Profile of Fibroblasts: The Role of Proteomics
Current Proteomics Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Current View from Alzheimer Disease to Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Toxic Metals in Herbal Medicines. A Review
Current Bioactive Compounds An Overview of Recent Patents on Nanosuspension
Recent Patents on Drug Delivery & Formulation Significance of 1,3,4-Oxadiazole Containing Compounds in New Drug Development
Current Drug Research Reviews Unequivocal Role of Pyrazine Ring in Medicinally Important Compounds: A Review
Mini-Reviews in Medicinal Chemistry Inhalation Gases or Gaseous Mediators As Neuroprotectants for Cerebral Ischaemia
Current Drug Targets Nanoemulsion: A Novel Eon in Cancer Chemotherapy
Mini-Reviews in Medicinal Chemistry Translational Optical Imaging in Diagnosis and Treatment of Cancer
Current Pharmaceutical Biotechnology Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry New Therapeutic Platforms for the Treatment of Epithelial and Cutaneous Lesions
Current Drug Delivery Kinase Phosphorylation-based Mechanisms of PARP Inhibitor Resistance During Synthetic Lethal Oncotherapy
Current Signal Transduction Therapy